跳至主要内容
临床试验/TCTR20230320012
TCTR20230320012已完成4 期

IMPACT OF PHARMACEUTICAL CARE ON CLINICAL AND HOLISTIC OUTCOMES AMONG SCHIZOPHRENIC PATIENTS

ational Research Council of Thailand (NRCT)0 个研究点目标入组 130 人开始时间: 2023年3月20日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
130

研究概览

简要总结

By providing the pharmaceutical care in schizophrenic patients, this can increase the safety use of antipsychotic drugs in the patients. Also, there is a tendency of a change in medication-taking behavior and increasing pharmaceutical therapy-related quality of life.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1.repeated inpatient treatment with antipsychotic drugs within 28 days from last hospital discharge or re-entering inpatient treatment for at least the third within a year due to risk of violence as defined by the Department of Mental Health 2) able to communicate with staff and caregivers in Thai

排除标准

  • 1. Persons whose doctors planned to provide electroconvulsive therapy (ECT) or who had received any form of electrical stimulation therapy and people with mental retardation. 2) patients causing violence while receiving pharmaceutical care or requiring transfer to another hospital for any reason.

研究者

发起方
ational Research Council of Thailand (NRCT)

相似试验

IMPACT OF PHARMACEUTICAL CARE ON CLINICAL AND... | 临床试验